Navigation Links
Halo Therapeutics Receives $500,000 MDA Award to Develop Drug for Duchenne Muscular Dystrophy
Date:11/14/2013

Newton, MA and Tucson, AZ (PRWEB) November 14, 2013

Halo Therapeutics LLC and the Muscular Dystrophy Association (MDA) today announced that $500,000 has been awarded for development of the experimental drug HT-100 as a treatment for Duchenne muscular dystrophy (DMD). The award to Halo, a subsidiary of DART Therapeutics Inc., comes from MDA Venture Philanthropy (MVP), part of MDA's translational research program.

HT-100 is an oral compound designed to combat excessive inflammation and scar formation ("fibrosis") in muscle tissue and to promote healthy muscle fiber regeneration. HT-100 is currently being tested in a multicenter clinical trial in 30 boys and young men with DMD.

DMD is one of nine types of muscular dystrophy, a group of genetic, degenerative diseases primarily affecting voluntary muscles. Caused by mutations in the gene that makes dystrophin (a protein that normally protects muscle cells and keeps them intact), DMD eventually weakens all skeletal muscles (including those used for breathing) and the heart. DMD affects approximately 1 in 3,500 boys with an estimated patient population exceeding 50,000 worldwide.

"We are extremely pleased to have the support of the MDA as we continue development of HT-100," said Marc Blaustein, DART's chief business officer. "This significant award comes at a crucial time, as we have transitioned to clinical testing of HT-100. Ours is a battle against the clock, and this funding from MDA's MVP helps ensure that we can continue rapid progress toward developing HT-100 as a therapy for boys and young men with DMD."

Jane Larkindale, MDA's vice president of research, said, "Excessive inflammation and fibrosis in muscle can interfere with muscle regeneration and can be a significant barrier
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. The Prostate Cancer Therapeutics Market 2013-2023
2. Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline
3. CFAST Sparks Pathways for Developing New Therapeutics for Unmet Patient Needs
4. Global NASH Therapeutics Market to Record 30% CAGR Through 2017, According to GlobalData Report Published at MarketPublishers.com
5. Global Melanoma Therapeutics Market 2012-2016
6. Fulgent Therapeutics Announces That CAP (College of American Pathologists) Has Accredited Their Clinical Laboratory
7. Multiple Myeloma Therapeutics Future Discussed in In-demand MP Advisors Report Published at MarketPublishers.com
8. American Assoc. for Cancer Research co-hosts conference on molecular targets and cancer therapeutics
9. Global Dermatophytic Onychomycosis Therapeutics Market 2012 - 2016: Worldwide Industry Latest Market Share, Growth, Size, Trends, Strategy And Forecast Research Report
10. Global Huntington’s Disease Therapeutics Industry
11. Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ... 06, 2015 , ... The Asian-Pacific market for rheumatoid arthritis therapeutics reached a ... at a CAGR of over 3.2 percent in the years to come to hit ... mainly spurred by an anticipated launch of a number of promising pipeline candidates and ...
(Date:7/6/2015)... ... July 06, 2015 , ... Cancer Hope Network (CHN) ... and medical professionals to chat with the CHN patient services team and connect ... cancer diagnosis is often the most traumatic experience of a person’s life,” said ...
(Date:7/6/2015)... Oakland, CA (PRWEB) , ... July 06, 2015 , ... ... Adults can learn how to reduce their risk of having a fracture through the ... Freedom From Fractures Awareness Day. , “We are participating because our residents need this ...
(Date:7/6/2015)... ... July 06, 2015 , ... Promero, a leading cloud hosting ... Unified IP contact center solution hosted by Promero. Randstad Technologies,a leading talent ... future call center platform. , Promero will implement and manage the private ...
(Date:7/5/2015)... Minneapolis, MN (PRWEB) , ... July 06, 2015 ... ... in the ancillary benefits market, is excited to announce the next generation of ... Plus and Advantage plans to now include two network options—Maximum Allowable Charge (MAC) ...
Breaking Medicine News(10 mins):Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2Health News:Cancer Hope Network Launches Upgraded Website to Support Cancer Patients, Caregivers 2Health News:National Bone Health Screening and Awareness Day 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 3Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2
... for Dental Research (IADR) is presenting its 2009 Oral ... the University of California, Los Angeles (UCLA), USA. The ... & Exhibition in Miami, Florida, USA, April 1, 2009. ... Beijing, China, in 1989, and a Ph.D. in genetics ...
... Conference March 19th at 10 a.m. in Falls Church ... Connolly, several prominent doctors from Inova Health System and public ... March 19th in Falls Church to call for quick passage ... Drug Administration (FDA) authority over tobacco products. The House ...
... About the High Cost of Preterm Birth , at U.S. ... medical costs that businesses pay to care for one premature ... a dozen healthy, full-term births, according to new statistics from ... medical cost for healthy full-term babies from birth through their ...
... Providing More Specific Guidance to Maximize Appropriate Aspirin Use ... Task Force (USPSTF) today strongly recommends that patients and ... heart attack and stroke, while considering benefits and risks. ... Annals of Internal Medicine , build on the ...
... Evaluation and Research (CDER), industry, and academia will convene at the ... 26-29; Arlington, VA) to discuss statistical methodologies and quantitative approaches in ... ... Horsham, PA (Vocus) March 17, 2009 -- Speakers from ...
... 17 The Health Resources and Services Administration (HRSA) ... of ways to prevent poisonings across the United States.HRSA ... Poison Prevention Week Planner March 17 at the ... National Poison Prevention Week, March 15-21. The downloadable ...
Cached Medicine News:Health News:U.S. Rep. Connolly, Inova Hospital Physicians, Public Health Groups Call for Congressional Action to Protect Kids From Tobacco 2Health News:Medical Costs for One Premature Baby Could Cover a Dozen Healthy Births 2Health News:Medical Costs for One Premature Baby Could Cover a Dozen Healthy Births 3Health News:U.S. Preventive Services Task Force Encourages Broader Aspirin Use to Prevent Heart Attack and Stroke 2Health News:U.S. Preventive Services Task Force Encourages Broader Aspirin Use to Prevent Heart Attack and Stroke 3Health News:U.S. Preventive Services Task Force Encourages Broader Aspirin Use to Prevent Heart Attack and Stroke 4Health News:Drug Information Association (DIA)and Food and Drug Administration (FDA) to Host 3rd Annual Statistics Forum 2Health News:HRSA Launches Online Resource to Help Prevent Poisonings 2
(Date:7/6/2015)... PARK, Calif. , July 6, 2015  Protiviti, ... its 2015 Internal Auditing around the World ... Protiviti has analyzed and reported on the evolution of ... companies from around the globe as a means to ... deeper understanding of this strategic business function. ...
(Date:7/6/2015)... July 6, 2015 E-QURE Corp (OTCQB: EQUR), ... live at VirtualInvestorConferences.com on July 9, 2015. ... http://tinyurl.com/e-qure-presentation This will be a ... ask the company questions in real-time - both in ... trade booth." If attendees are not able to join ...
(Date:7/6/2015)... BOULDER, Colo. , July 6, 2015 /PRNewswire/ ... inhibitor, encorafenib, was showcased this past weekend at ... during an oral presentation.  At the meeting, data ... preliminary data from a 100-patient randomized Phase 2 ... encorafenib and cetuximab, an EGFR inhibitor, with or ...
Breaking Medicine Technology:New Edition of Internal Auditing Around the World from Protiviti Explores Changes and Trends 2E-QURE Corp to Webcast, Live, at VirtualInvestorConferences.com July 9 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 3Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 4
... (Nasdaq: BIOD ) announced today that it will be ... JMP Securities Healthcare Conference, September 28, 2010 at 12:00 pm Eastern ... Interested parties can access a link to the live webcast of ... website www.biodel.com . Replays of the presentation will be available ...
... today announced that six-month follow-up clinical trial data ... the company,s Genous Bio-engineered R stent in combination ... de novo coronary artery disease. The data were ... Germany, principal investigator of the study, in the ...
Cached Medicine Technology:OrbusNeich's Genous™ Bio-engineered R stent™ Shows Favorable Safety Profile and Clinical Outcomes in Combination with Paclitaxel-Coated Balloon for De Novo Coronary Artery Disease 2OrbusNeich's Genous™ Bio-engineered R stent™ Shows Favorable Safety Profile and Clinical Outcomes in Combination with Paclitaxel-Coated Balloon for De Novo Coronary Artery Disease 3
... The HAAG-STREIT OM 900 Ophthalmometer uses a ... three requirements of Helmholtz: 1. The size ... the distance between the Ophthalmometer and the ... independent of the distance between the Ophthalmometer ...
... complete image capture and management application that ... leading ophthalmic clinicians, ophthalmic photographers and optometrists ... securely document the eye via the slit ... slit lamps equipped with digital or video ...
Advanced Corneal Topography System with integrated Keratometer. Keratometric and topographic measurements all in one instrument....
The Haag-Streit 81 D lens is a powerful tool for biomicroscopy as well as laser treatment of the fundus. Due to its asymmetric configuration it provides better observation parameters combined with im...
Medicine Products: